# Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients

> **NCT05405556** · PHASE2 · COMPLETED · sponsor: **Martina McGrath, MD** · enrollment: 40 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DIAGNOSTIC_TEST:** eGFR reporting

## Key facts

- **NCT ID:** NCT05405556
- **Lead sponsor:** Martina McGrath, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-17
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-11-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405556, "Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05405556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*